Completed PHASE4 INTERVENTIONAL 2-arm NCT00189618

The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)

The Effects of Physical Training, Aspirin, and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease

Sponsor: Arteriogenesis Competence Network

Conditions Peripheral Arterial Disease

Interventions Aspirin Clopidogrel

Updated 6 times since 2017 Last updated: Oct 3, 2008 Started: May 31, 2005 Primary completion: Apr 30, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Peripheral Arterial Disease and is currently completed. Arteriogenesis Competence Network leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Arteriogenesis Competence Network

Data source: Arteriogenesis Competence Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Basel, Switzerland , Bellinzona, Switzerland , Berlin, Germany , Bruderholz, Switzerland , Darmstadt, Germany , Dresden, Germany , Frauenfeld, Switzerland , Karlsbad, Germany , Lausanne, Switzerland , Liestal, Switzerland and 5 more locations